1. No category

2ND GULF LIVER
SUMMIT
H.H. Sheikh Mohammed Bin Rashid Al Maktoum
Vice President, Prime Minister and Ruler of Dubai
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
WELCOME MESSAGE
Dear Colleagues,
First of all, let me welcome you at your second home in the United
Arab of Emirates and in the city of Dubai, which has the honor to
host you in the 2nd Gulf Liver Summit in collaboration with Houston
Methodist Hospital, which is launched today Under the patronage of
Chairperson of Dubai Healthcare City Authority HRH Princess Haya
Bint Al Hussein, Wife of HH Sheikh Mohammed Bin Rashid Al
Maktoum, Vice-President and Prime Minister of the UAE and Ruler of
Dubai.
Following the major success of the First edition – The 1st Gulf Liver
Summit held on 25th and 26th, January 2013, here we are two years later enjoying - The 2nd
Gulf Liver Summit in collaboration with Houston Methodist Hospital.
The 2nd Gulf Liver Summit in collaboration with Houston Methodist Hospital project is focusing
on viral hepatitis, hepatocellular carcinoma, metabolic liver diseases and liver transplant. It
will provide practicing professionals in the gulf with the latest innovations in technology,
treatment strategies and best practices in the field of liver transplant that can directly enhance
practice and patient care. The conference is bringing together experts involved in the
management of liver diseases and will create an excellent platform where participants can
meet, network and share with experts & peers from across the gulf.
We are happy to attract participants from the (UAE, Oman, Oatar, Kuwait, Bahrain, Saudi
Arabia, Egypt, Jordan, United States of America, United Kingdom, France, Germany, Italy,
Russia, Kazakhstan and India). The scientific program boasts world renowned international
faculty who are pioneers in the respective fields as well as renowned faculty from the region
who have been instrumental in establishing best practices in Hepatology and
Gastroenterology in the Gulf.
Wishing a pleasant stay for you and all development and success for your conference.
Conference Chairperson
Dr. Adnan Abuhammour
AMC, Dubai – The U.A.E.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
CME & USEFUL INFORMATION
CME ACCREDITATION:
• This Conference is CME accredited with 13.5 CME credit hours from The Dubai Healthcare City.
• Please scan your badge every time you enter to the Conference Hall.
• CME Certificates will be obtained starting April 7th, 2015, through the Conference website:
www.InfoPlusEvents.com/Liver
• Delegates should log in using the registration number on your badge, fill the evaluation form and
you will be able to download your certificate.
The deadline to download your CME Certificate is May 7th, 2015.
FOOD & BEVERAGE:
Coffee break will be open to registered delegates. Meal will be offered against daily vouchers provided
with the delegate badges.
REGULATIONS:
Please keep your mobile phones on silent mode while in the conference room.
IMPORTANT CONTACT NUMBERS
Mr. Ahmed Hajeer
Project Management
+971 55 405 1712
Mr. Nahas Nazarudeen
Registration Management
+971 50 762 0590
Ms. Julia Mchenga
Speakers’ Management
+971 56 931 8602
http://on.fb.me/1tP21RJ
http://bit.ly/1BNr9bC
http://bit.ly/1zOaTrx
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
SCIENTIFIC COMMITTEE
Adnan Abuhammour, MD
United Arab Emirates
Ali Al Fazari, MD
United Arab Emirates
Asad Dajani, MD
United Arab Emirates
Emad Fayyad, MD
United Arab Emirates
Mazin Aljabiri, MD
United Arab Emirates
Jihad Qumaish, MD
Bahrain
Howard Monsour, MD
United States of America
Christophe Duvoux, MD
France
Christophe Hezode, MD
France
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
DAY 1 VIRAL HEPATITIS / MISCELLANEOUS
MORNING SESSION ACTIVITIES
07:30 AM - 08:30 AM Registration
HCV FROM DISCOVERY TO CURE
Moderators: Emad Fayyad (UAE), Ziad Sharaiha (Jordan)
Hepatitis C, Global Epidemiology, Natural History And Extra-Hepatic Manifestations
IFN Free Treatment Options: Available Agents And Drugs In The Pipeline
Treatment of HCV: Naïve, Relapsers And Non-Responders
Treatment Of Hep C In Liver Transplant Candidates And Recipients In The DAA Era:
Recommendations From The 2015 ELITA Monothematic Conference
09:50 AM - 10:10 AM Achieving High Certainty Of Cure for HCV Patients
10:10 AM - 10:20 AM Innovative Discussion
10:20 AM - 10:45 AM OENING CEREMONY
08:30 AM - 08:50 AM
08:50 AM - 09:10 AM
09:10 AM - 09:30 AM
09:30AM - 09:50 AM
David W. Victor (USA)
Christophe Hezode (France)
Holger Hinrichsen (Germany)
Christophe Duvoux (France)
Jean Michael Pawlotsky (France)
HEPATITIS C IN LOCAL VIEWS
10:45 AM - 11:00 AM
11:00 AM - 11:15 AM
11:15 AM - 11:30 AM
11:30 AM - 11:45 PM
11:45 AM - 12:00 PM
12:00 AM - 12:15 PM
12:15 PM - 14:00 PM
Moderators: Mamdouh Ahmed Gabr (Egypt), Asad Dajani (UAE)
Egypt
Kuwait
United Arab Emirates
Qatar
Kingdom Of Saudi Arabia
Innovative Discussion
PRAYER AND LUNCH BREAK
Gamal Esmat (Egypt)
Fuad Al Ali (Kuwait)
Salim Awadh (UAE)
Muneera Al Mohannadi (Qatar)
Hussien Elsiesy (KSA)
AFTERNOON SESSION ACTIVITIES
HCC AND METABOLIC LIVER DISEASE
14:00 PM - 14:20 PM
14:20 PM - 14:40 PM
14:40 PM - 15:00 PM
15:00 PM - 15:20 PM
15:20 PM - 15:40 PM
Moderators: Mazen Taha (UAE), Mahmoud Omar (Kuwait)
Genetic Liver Disease: Hemochromatosis, Wilson’s Disease Natural History And Treatment
Hepatocellular Carcinoma: Screening, Initial Management, Targeted Therapies And Transplantation
Selective Internal Radiation Therapy In Inoperable HCC
Treatment: Experience From Bahrain
COFFEE BREAK
David W. Victor (USA)
R. Mark Ghobrial (USA)
Daniel Palmer (UK)
Ali Albaqali (Bahrain)
HBV
Moderators: Suleiman Nayal (UAE), S. P. Dore (UAE)
15:40 PM - 16:00 PM Hepatitis B: Global Treatment Strategies And Future Treatments
16:00 PM - 16:15 PM Treatment Experience From UAE
16:15 PM - 16:30 PM Facts And Fictions About Occupational Risks Of Hepatitis B Virus (HBV):
A Tale Amongst Health Care Provides (HCPs)
David W. Victor (USA)
Zaher Koutoubi (UAE)
Ahmed Al Hazemi (KSA)
MISCELLANEOUS TOPICS
Moderators: Azzam Kayasseh (UAE), Asthana (UAE)
16:30 PM - 16:45 PM State Of Art Lecture: How To Optimize The Treatment Of HCV Genotype 4 Patients
16:45 PM - 17:05 PM Liver In Celiac Disease
17:05 PM - 17:20 PM Assessment Of Biliary Disorders In Cholestatic Liver Disease
17:20 PM
Innovative Discussion And Closing
www.InfoPlusEvents.com/Liver
Christophe Hezode (France)
Salem Awadh (UAE)
Laura Kassym (Kazakhstan)
2ND GULF LIVER
SUMMIT
DAY 2 LIVER TRANSPLANT/ MISCELLANEOUS
MORNING SESSION ACTIVITIES
CIRRHOSIS AND ITS COMPLICATIONS
08:30 AM - 08:50 AM
08:50 AM - 09:10 AM
09:10 AM - 09:30 AM
09:30 AM - 09:50 AM
09:50 AM – 10:10 AM
10:10 AM - 10:30 AM
10:30 AM – 10:50AM
Moderators: Subash Gautam (UAE), Abdel Meguid Kassem (Egypt)
Non-Invasive Markers Of Liver Fibrosis
Focal Lesion In Non Cirrhotic Liver
Bacterial Infections In Cirrhosis: Pathogenesis And Current Treatment
Management Of Refractory Ascites
Management Of Variceal Bleeding
Innovative Discussion
COFFEE BREAK
Sameh Fakhry (UAE)
Christophe Duvoux (France)
Jose Such (UAE)
Tarek Qutob (Jordan)
Ali Al Fazari (UAE)
LIVER TRANSPLANTATION
10:50 AM - 11:10 AM
11:10 AM - 11:30 AM
11:30 PM - 11:50 AM
11:50 AM - 12:10 PM
12:10 PM - 12:30 PM
12:30 PM - 12:50 PM
12:50 PM - 13:00 PM
13:00 PM - 14:00 PM
Moderators: AlaaEldin Ibrahim (UAE), Jawahar Mathias (UAE), Huda Kataa (UAE)
When To Refer To A Transplant Unit And How To Manage During Waiting
Outcomes Of Transplantation (MELD Score)
Toward An Expansion Of Liver Transplantation Criteria For HCC: How The AFP Model Can Help
Immunosuppression In Liver Transplantation
Immunizations In Transplant Pts. And Travel Advice For Transplant Pts.
Living Donor, Lessons learned And Future Recommendations
Innovative Discussion
LUNCH
Shiva Kumar (UAE)
R. Mark Ghobrial (USA)
Christophe Duvoux (France)
R. Mark Ghobrial (USA)
Victor Fainstein (USA)
Kaiser Raja (India)
AFTERNOON SESSION ACTIVITIES
NAFLD, DRUG LIVER DISEASE
14:00 PM - 14:20 PM
14:20 PM - 14:40 PM
14:40 PM - 15:00 PM
15:00 PM - 15:10 PM
15:10 PM - 15:30 PM
Moderators: Mahmoud Hamouri (UAE), Amany Hanna (UAE)
NASH: Epidemiology, Natural History And Treatment
Statins and ARBs In NAFLD
Gut Liver Interaction
Innovative Discussion
COFFEE BREAK
David W. Victor (USA)
Oxana Drapkina (Russia)
Maurizio Pompili (Italy)
MISCELLANOUS LIVER DISEASE AND INTERACTIVE CASES
15:30 PM - 15:50 PM
15:50 PM - 16:10 PM
16:10 PM - 16:30 PM
16:30 PM - 16:50 PM
16:50 PM - 17:10 PM
17:10
Moderators: Mohammed Nounou (UAE), Thomas Cherukara (UAE)
Drug Induced Liver Injury
Liver In IBD
Approach To The Diagnosis And Management Of Liver Abscess
Case Study 1
Case study 2
Closing & Adjourn
Kote Shamsheer (UAE)
Makki Fayadh (UAE)
Juma Al Lawati (Oman)
Ajit Tharakan (UAE)
Abdul Hamid Sinan (UAE)
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
INTERNATIONAL FACULTY
R. Mark Ghobrial, MD
United States of America
David W. Victor, MD
United States of America
Victor Fainstein, MD
United States of America
Daniel Palmer, MD
United Kingdom
Christophe Duvoux, MD
France
Christophe Hezode, MD
France
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
INTERNATIONAL FACULTY
Jean Micheal Pawlotsky,
MD
France
Holger Michael Hinrichsen,
MD
Germany
Maurizio Pompili, MD
Italy
Oxana Drapkina, MD
Russia
Laura Kassym, MD
KazakhstaN
Kaiser Raja, MD
India
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
REGIONAL FACULTY
Juma Al Lawati, MD
Oman
Muneera Al Mohannadi,
MD
Qatar
Fuad El Ali, MD
Kuwait
Mahmoud Omar, MD
Kuwait
Ali Albaqali, MD
Kingdom of Bahrain
Ahmed Al Hazemi, MD
Kingdom of Saudi Arabia
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
REGIONAL FACULTY
Hussien Elsiesy, MD
Kingdom of Saudi Arabia
Abdel Meguid Kassem, MD
Egypt
Gamal Esmat, MD
Egypt
Mamdouh Ahmed Gabr,
MD
Egypt
Tarek Qutob, MD
Kingdom of Jordan
Ziad Sharaiha, MD
Kingdom of Jordan
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
UAE FACULTY
Abdul Hamid Sinan, MD
United Arab Emirates
Adnan Abuhammour, MD
United Arab Emirates
AlaaEldin Ibrahim, MD
United Arab Emirates
Ajit Tharakan, MD
United Arab Emirates
Ali Al Fazari, MD
United Arab Emirates
Amany Hanna, MD
United Arab Emirates
Asad Dajani, MD
United Arab Emirates
Azzam Kayyaseh, MD
United Arab Emirates
Emad Fayyad, MD
United Arab Emirates
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
UAE FACULTY
Huda Kataa, MD
United Arab Emirates
Jawahar Mathias, MD
United Arab Emirates
Jose Such, MD
United Arab Emirates
Kote Shamsheer, MD
United Arab Emirates
Mahmoud Hamouri, MD
United Arab Emirates
Makki Fayadh, MD
United Arab Emirates
Mazen Taha, MD
United Arab Emirates
Mazin Aljabiri, MD
United Arab Emirates
Mohammed Nounou, MD
United Arab Emirates
Salem Awadh, MD
United Arab Emirates
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
UAE FACULTY
Sameh Fakhry, MD
United Arab Emirates
Saubash Gautam, MD
United Arab Emirates
Shiva Kumar, MD
United Arab Emirates
Suleiman Nayal, MD
United Arab Emirates
S. P. Dore, MD
United Arab Emirates
Thomas Cherrukara, MD
United Arab Emirates
Zaher Koutoubi, MD
United Arab Emirates
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FLOOR PLAN
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
ABDUL-HAMID SINAN
General Manager
Surgical Consultant
Head of Surgery Department,
Al Sharq Hospital, Fujairah, UAE
Dr. Abdul Hamid Sinan is a consultant laparoscopic General surgeon, he is the General Manager
of Al Sharq Hospital, Fujairah, UAE.
Dr. Sinan is an HPB & Liver and Multi- Organ Transplant Surgeon. Upon graduating as a general
surgeon he pursed Master's in liver transplantation at McGill University, Canada. He then moved to Dalhousie university,
and to University of western Ontario, Canada, where he completed his fellowship in Liver transplantation and obtained his
license and became accredited by The American Society of Liver Transplantation. He completed Pancreas & Kidney
transplant fellowship at University of Calgary, Canada.
Along with the Siro Lebanese Hospital, São Paulo, Brazil Dr. Sinan contributed in establishing the first Liver Center in Syria.
Dr. Sinan is a member of The Canadian General Surgeon association, and fellow of the International Society Surgeons A
member of the Syrian Executive Transplant Committee.
ADNAN ABUHAMMOUR
MD,MsC
Dr Abuhammour obtained his MBBS (with honor) from the University of Jordan, in 1984.Then
he completed his internal medicine residency and obtained his Master degree in internal
medicine (with honor) from the University of Jordan in 1987.
Dr Abuhammour is American Board certified in internal medicine and gastroenterology.
He has done his residency in internal medicine and fellowship in Gastroenterology at the
University of Illinois’ in Chicago. In addition he has completed one year of fellowship in advanced
therapeutic endoscopy at the same University in USA.
In 2011, Dr Abuhammour obtained his Diploma in health care management from the Royal College of Surgeons Irland.
On moving to Dubai in 1997, Dr Abuhammour was appointed as chairman of the department of medicine at the American
Hospital until 2005 when he founded the Abuhammour Medical Center at Dubai Health Care City.
Dr Abuhammour was the past President of the Emirates Medical Association Division of Gastroenterology (EMAGI)
In 2011 Dr Abuhammour was appointed as a member of the Dubai Health Care City Authority.
Dr Abuhammour has published many articles, medical reviews, editorials and book chapters. He has organized many
regional medical conferences and he received a variety of honors and recognition awards from different medical and
gastroenterology societies.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
PROF. ALAAELDIN IBRAHIM (MD)
Have been graduated from Cairo University on 1978. Awarded the title of full Professor of Internal
Medicine, University of Benha, Egypt on 1996 . Have been the Chair of division of hepatology and
Gastroenterology, University of Benha , Egypt between 1999-2008 then after he have been the Chair
of Medicine and hepatogastroenterology, Al Salama Hospital, Abu Dhabi, UAE Have been trained in
internal medicine, hepatology and gastroenterology in Cairo and Benha University hospitals. Abroad
have been trained at the Royal free Hospital and Middle sex hospital and StMark’s hospital, London,
UK and Harvard’s University, USA. Have been visiting Professor and Guest lecturer in Many
recognized hospitals and medical schools in the Arab, Gulf region, Europe and Asian. He was the
co-Chair of the 3rd APASL STC on liver fibrosis held in Cairo 2008 and the secretary general of APASL STC held in Cairo 2014.
Have many local and international publications. Shared as a faculty member and international organizers in many International
events and in putting many national and international guidelines in the field of hepatology. Recently shared in putting APASL HCV
guidelines. Currently he is sharing as one of the APASL research team in the current prospective study on ACLF.
He is a member of APASL, EASL, ASGE and CHBG. He is an international instructor for evidence –based medicine and sharing
as reviewer in many local and international Journals. Currently he is an executive council member and vise-Chair of the educational
committee of APASL .
AJIT THARAKAN
General Manager
Surgical Consultant
Head of Surgery Department,
Al Sharq Hospital, Fujairah, UAE
Dr Tharakan obtained his MBBS and MD (internal medicine) from the prestigious Kasturba
Medical College in India. Subsequently had his DM (Gastroenterology) training from GB Pant
Hospital, Maulana Azad Medical College, New Delhi.
Dr Tharakan is one of the leading gastroenterologists with special interest in hepatology. He has to his credit a number of
research publications and also has co-authored chapters in several text books.
Dr Tharakan is the founding secretary of the Indian Society of Gastroenterology - Middle East Chapter. He is the immediate
past secretary of the Emirates Gastroenterology Society.
A keen academician and an astute physician, Dr Tharakan is a well-known figure in the academic circles in UAE and India,
who has delivered several lectures in various forums
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
ALI AL FAZARI
Assistant Professor of Medicine
Consultant Gastroenterologist
Department of Internal Medicine
College of Medicine & Health Sciences
Dr. Ali Al Fazari is Canadian Board Certified Gastroenterologist and is a consultant
gastroenterologist at Tawam Hospital, Al Ain. Dr. Ali is also the Chairman of Higher Professional
Training Committee at the College of Medicine, UAE University. Dr. Ali academic and research
interests are in hepatic toxicology, drug screening and gastric carcinogenesis. He published
numerous original research articles in peer reviewed international journals.
AMANY TALAAT HANNA
Professor internal medicine, Gastroenterology and Hepatology.
Ain Shams Medical School, Cairo, Egypt
Specialist Gastroenterology, Alzahra Private Hospital Sharjah, Dubai
I graduated and finished my internship and residency in Cairo in Ain-Shams Medical School hospitals.
During that period, finished my Master thesis & exam in 1992. I finished my MRCP (UK) in 1998 then
got a grant to do my PhD thesis in Nine Wells University Hospital in Scotland as a joint project
between Ain-Shams Medical School and Dundee University. I have been teaching and practicing
medicine ever since in Cairo. I supervised many master and MD thesis in the field of Gastro and
Hepatology. I also published few studies in national, regional and international Journals. I was involved in the postgraduate teaching
and examination for our newly developed system of Gastro Board, designed to be granted as a specialty degree in Gastroenterology
& Hepatology. I am an active member of the Egyptian society of Gastroenterology, Hepatology & Endoscopy. I am also participating
in many Gastro & Hepatology conferences as a delegate as well as a speaker. In 2013, I was appointed and still working in Alzahra
private hospital in Sharjah as a specialist gastroenterology, on a secondment basis from Ain-Shams University.
ASAD DAJANI
Dr Asa’d Izziddin Dajani obtained his Medical degree from the Faculty of Medicine, Cairo
University in Egypt. He pursued his postgraduate studies and activities in internal medicine in
the UK, USA and Austria.
Dr Dajani has an experience of having worked at various hospitals in Egypt, Kuwait and Vienna,
gaining wide experience in his field. In 1984, he relocated to UAE, where he was instrumental
in establishing the Endoscopy service at the Kuwait Hospital in Sharjah.
Dr Dajani regularly attends local, regional as well as international conferences and shares his
expertise with his peers all over. He is regularly invited as a guest lecturer to various medical conventions, institutes, and
pharmaceutical sponsored meetings locally, regionally and interna- tionally. Dr Dajani has many publications to his credit
in reputed local as well as international Medical journals. He has also presented to many conferences and seminars
worldwide.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
AZZAM KAYASSEH MD,
AEPS, DU, DIS, FACG
CEO/Medical Director,
Dr. Kayasseh Medical Clinic
Digestive Endoscopy Center, Dubai,UAE
He had M.D. (University of Damascus, Syria, 1978),D.U. in Digestive Endoscopy (Nice, France,
1989),D.I.S. in Hepato-Gastroenterology (Nice, France, 1993), and his thesis was : Endoscopic
Hemostatic Treatment of Bleeding Ulcers (By Local Injections) Sept. 1988 – March 1993 (80
pts).
Dr. Kayasseh is a founder member of EGHS-EMA (1994).
Dr. Kayasseh was actively involved in the education committee of WEO (2010-2013) nationally and internationally, and he
is an active member of ACG International Relation Committee (2010-2015) and now he is a WGO Guideline Committee
member (2013-2015).
Dr. Kayasseh is an active OESO;General Delegate and Head of the Middle East and Africa Region (since 2011) and an
Ambassador of Dubai Convention and Event Bureu (DCEB);AlSafeer Program ( since 2012).
He started his dream (Dr. Kayasseh’s Pre- and Post-Liver Transplantation Care program in Dubai, UAE) since 2006 which
is affiliated with the International Liver Centers. He have succeeded in a couple of cases that achieved a new hopeful life.
Recently in November 2014 he had got a Fellowship from Royal College of physians and Surgeons of Glasgow- FRCP
(Glasg)
Dr. Kayasseh’s mission is to provide a unique medical service which offers humanizing care while achieving the highest
quality of life as his Patients are his Life and his Truth (Dr. Kayasseh “Care To Cure” programs in Hepatogastroenterology
and in Digestive Endoscopy). With his wealth of experience, Dr. Kayasseh delivers a quality practice for his patients in
upper and lower G.I. endoscopy and liver disorders.
EMAD FAYYAD MD
Medical school in Romania Cluj Napoca university Iuliu Hatieganu 1992 followed by master in
gastroenterology 6 years in same university, then advanced interventional endoscopy & ERCP 2
years. Became an expert in hepatobiliary & pancreatic disease .
Special interest on ultrasound GI tract followed by endoscopic ultrasonography in France .
Worked in Dubai health authority 9 years as specialist Gastroenterologist
Moved to private sector Medcare hospital in 2009 as a consultant gastroenterology & head of
department.
Special interest in interventional endoscopy , ultrasonography , inflammatory bowel disease &
hepatolgy.
Developed department of gastroenterology & advanced interventional endoscopy ( team of 4 gastroenterologist).
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
HUDA KATAA
American European Medical Center
Consultant Gastroenterologist
City of Residence : Abu Dhabi
Member of the Royal College of Physician ( UK)
Member of the British Society of Gastroenterology
Member of the taskforce for colorectal cancer screening HAAD - Abu Dhabi
Previously employed in Mafraq Hospital - Abu Dhabi
Special interests : IBD , Viral hepatitis .
KOTE SHAMSHEER
Dr Kote Samsheer is a gastroenterologist certified in colonoscopy, gastroscopy, general
gastroenterology and hepatology. He studied medicine at Kasturba Medical College, Mangalore
in India. Over the last 11 years he has trained as a specialist physician in various hospitals
across England. Dr Samsheer completed his gastroenterologist training with the London
Deanery.In addition to general gastroenterology including indigestion, abdominal pains, colon
cancer surveillance, he has a particular interest in inflammatory bowel diseases, Irritable bowel
syndrome, endoscopy and nutrition.Dr Samsheer specialises in Wireless (Video) Capsule
Endoscopy which is a test for examining the small bowel, by swallowing an electronic capsule
which takes pictures as it travels through the small intestine.His aim is to provide the best in health care for all conditions
related to the gastrointestinal tract and the liver.
JOSE SUCH
MD, PhD. Associated Professor of Medicine,
Miguel Hernandez University, Alicante, Spain
Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
Consultant. Gastroenterology and Hepatology.
Digestive Disease Institute.
City of Residence: Abu Dhabi, UAE
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
MAKKI HUMMADI FAYADH
Consultant physician &gastroenterologist-advanced center for day care surgery abu dhabi.
Founder of the iraqi society of gastroenterology and hepatology 1992 and president for the
society from 1998 till 2014
Founder and director of the gastroenterology and hepatology teaching hospital in baghdad-iraq
1994 till 2005.
Founder and supervisor and trainer to the iraqi board of gastroenterology 1996 till 2005.
Founder and editor/ iraqi journal of gastroenterology.
Published (47) papers.
Supervised 19 theses in various git and liver diseases.
Produced (12) teaching films in various aspects of endoscopy.
Introduced all the new techniques in endoscopy and guidelines for various git and liver diseases in iraq.
Chief editor iraqi journal of gastroenterology
International editor gie
MAZEN TAHA
Dr. Mazen Taha accomplished his training in Medicine and Gastroenterology/Hepatology in Dresden
and Berlin –Germany.
He assigned 1994 as Chief of Endoscopy in University Hospital - Dresden and fellowship program
Director for Gastroenterology.
In 1998 he assigned as a Head of Gastroenterology and Hepatology Department in University
hospital Dresden –Germany
Since 2002 he is senior Consultant in Gastroenterology /Hepatology and Chief of Gastroenterology in Tawam Hospital
Since 2004 is the Chairman of Internal medicine in Tawam Hospital in affiliation of Johns Hopkins in Al Ain –Abu Dhabi
He is Clinical associated Professor in Faculty of Medicine and Health Science in UAE University.
Member of the German Society of Gastroenterology
Member of German Society of Endoscopy and Imaging
Dr.Mazen Taha has numerous Publications and poster in International medical journal mainly in GI oncology and Endoscopy.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
MAZIN RASOOL ALJABIRI
General Physician and Gastroenterologist, Accredited Bowel cancer Screener
(UK), ESD & EPMR Accredited Tokyo/Japan
Dr. Aljabiri has recently relocated to Dubai from the UK and joined Mediclinic Dubai Mall and
Mediclinic City Hospital as a Consultant Physician and Gastroenterologist.
With more than 15 years experience in gastroenterology, Dr. Mazin held a Consultant
Gastroenterologist and General physician post in one of the teaching university hospitals in the
UK. He has taken a post as an IBD (Inflammatory Bowel Disease) Lead. He has vast experience
in endoscopy and has performed more than 4,000 colonoscopies and 10,000 gastroscopies.
Dr. Mazin is also experienced in managing difficult ERCP cases and pancreatic endotherapy. He has a keen interest in
Inflamatory Bowel Disease and hepatology.
He has worked in one of the leading Liver transplant centers units in the UK, as he worked at the Royal Free Hospital/
London. His experience extends to managing patients with Acute, Chronic , sub-acute and Fulminant hepatic failure, also
manages patients with Hepatitis B and C with the recent up to date treatment.
Dr. Aljabiri is an intervention endoscopist – JAG Accredited /RCP-UK who is experienced in oesophageal / pyloric / duodenal
and colonic balloon dilatations and stent insertions. His main interest is intervention endoscopy, including bowel cancer
screening and performed more than 1000 polypectomies for which he also received training in Japan including EPMR and
Endoscopic Submucosal Dissection (ESD).
Dr Mazin is very active on the medical education field, presenting regular abstracts and lectures at national and international
conferences and writing up papers as well as teaching membership courses for the Royal College of Physicians UK.
MAHMOUD HAMOURI
Consultant internist/gi/hepatologist – baraha hospital –dubai – uae
Associat professr of clinical medicine – faculty of medicine – sharjah university
Mbbch alex., msc.alex.,jord.medical board ,mrcp(uk),frcp(edin),frcp(glass).
Shared in many clinical studies in the field of hepatology and gastroenterology diseases ,very long
experience in treating all types of viral hepatitis.
Member of many hepatology and gastroenterology local and international associtions.
MOHAMED EL NOUNOU, M.D.
Specialist GI. & Liver Diseases
MNC - Sharjah
Chairman
City of residence: Sharjah
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
SALIM AWADH
SENIOR CONSULTANT PHYSICIAN,
GASTROENTEROLOGIST & HEPATOLOGIST
Diplomas & Registration:
1. ECFMG – U.S.A.
2. Evaluating Exam. – Canada.
3. GMC Registration – U.K. 1982
Awards :
1. Memership Quiz Award – University of Newcastle – 1975
2. Shaikh Rashid Postgraduate Award – 1991
SAMEH FAKHRY
Dr. Sameh Mohamed Fakhry is a Professor of Gastroenterolgy, Hepatology and Endoscopy,
Cairo, Egypt. Currently, he is consultant in Abu Dhabi Police Medical Services. He finished his
medical education in the Faculty of Medicine, Cairo University in 1982 Then finished his master
degree and PhD from Cairo University as well. He received fellowship training in the field of
Gastroenterology, Hepatology and Endoscopy In USA between 1989-1994 in the University of
Southern California, Los Angeles; Duke University, North Carolina and Cleveland Clinic,
Cleveland, Ohio.
SUBASH GAUTAM
FUJAIRAH HOSPITAL FUJIARAH UAE
HEAD DEPT OF SURGERY, PROFESSOR OF SURGERY AT RAKMHSU
BI Dr Subash C Gautam MBBS Panjab, FRCS Edinburgh 1975,FRCS England 1977,FRCS Glasgow
2000, FACS 1989,Hon FRCS Glasgow 2013, Hon FCPS 2013
Trained in surgery in King Gerorge Hospital Ilford UK and obtained CCST certification from PMTEB
United Kingdom.
Professor of Surgery RAKMHSU Ras Al Khima
Associate Professor FHMS UAE University Al Ain(adj.)
Advisor to Royal College of Physicians and surgeons Glasgow
Head Dept of surgery Fujairah Hospital
Examiner Intercollegiate MRCS and FRCS International
Chairman ATLS MENA,Awarded highest award for spreading Trauma care training in 2009 Internationally by American College of
Surgeons.
Ex Chairman Emirate Gastro-Hepatology Society UAE, Board member and Office bearer for 5 terms with founder office bearer,
Involved with Emirates Gastro-Enterology conferences from First Conference in 1986.
Author of publication in Gastroenterology on Upper GIT endoscopy, Laproscopic Surgery and trauma in national and international
journals.Invited to national and international forum as speaker,chairperson and moderator.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
SHIVA KUMAR
Dr. Kumar completed his residency & chief residency in Internal Medicine in New York, subspecialty fellowship training in Gastroenterology & Hepatology at the Mayo Clinic in Rochester,
Minnesota and additional clinical and research training in Hepatology at the Liver Unit of the
University of Texas Southwestern Medical Center in Dallas, Texas. He also completed a Master
of Science program in Healthcare Management from the University of Texas at Dallas Jindal
School of Management.
Dr. Kumar served as medical director of liver transplantation and primary liver physician at two
liver transplant centers in the US for more than eight years prior to joining the Cleveland Clinic
- initially at the Ochsner Clinic in New Orleans, Louisiana and subsequently at Aurora St. Luke's Medical Center in
Milwaukee, Wisconsin. He was also Director of Hepatology sub-specialty fellowship training at Ochsner Clinic and Clinical
Adjunct Associate Professor of Medicine at the University of Wisconsin School of Medicine & Public Health. Dr. Kumar is
certified by the American Board of Internal Medicine (ABIM) in Internal Medicine, Gastroenterology & Transplant Hepatology.
He is a fellow of the American College of Gastroenterology (ACG), American Society of Gastrointestinal Endoscopy (ASGE)
and American College of Physicians (ACP) and has served on many committees of national scientific societies. He has
received many awards during his career including American College of Gastroenterology Annual Scientific Meeting
Presidential Poster Awards in 2004 & 2014. He has numerous publications and presentations at national & international
scientific meetings, with a primary focus on liver disease and transplantation and has also served as primary site investigator
in numerous clinical trials including those of newer therapeutic agents in hepatitis C.
SULEIMAN NAYAL
MBBch – FRCP - FACG
Specialist Physician and Gastroeneterologist . Part Owner of The Polyclinic. Fellow of The Royal
College Of Physician of Ireland. Fellow of The American College of Gastroenterology
PROFESSIONAL & COMMUNITY ACCOMPLISHMENTS
Board Member of Gastroenterologist Society in UAE and Pan Arab
Member of European Hepatology and Gastroenterology
Board Member of The Gastroenterology Division of Emirates Medical Association
Ex-President of The Syrian Business Council Dubai and Northern Emirates
Member of Who’s Who of Professionals since 2003
S. P. DORE
Gastroenterologist
Since 1997, Dr. Doré has been the Head of the Department of Gastroenterology at the Al Zahra
Medical Center in Dubai.
Dr. Doré is a Board Certified Internist and Gastroenterologist from the University of Leuven, Belgium
and has received his M.D. from the University of Bern, Switzerland and his MBBS from St. John’s
Medical College, Bangalore,India.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
THOMAS CHERUKARA
Clinical Gastroenterology & Liver Unit
Al Qassimi & Kuwait Hospitals (MOH)
Sharjah , United Arab Emirates.
BEST RESEARCH PAPER AWARDS:
Association of Physicians of India, Annual Meeting, July 1992, for a paper titled ‘Triple Therapy vs
Omeprazole in Refractory Duodental Ulcer’. Indian Medical Association, Kerala Chapter Annual
Meeting, November 1992, for a paper titled ‘Pneumatic Dilation vs Surgery in Achalasia Cardia. Indian
Society of Gastroenterology, Kerala Chapter, September 2000, for a paper titled, ‘Laparoendoscopy
– A new approach to evaluate small bowel’
EXCELLENCE AWARD
Excellence Award given by Al Qassimi Hospital Administration for exemplary work for the year 2009.
Currently: Senior Consultant, Gastroenterology & Endoscopy Services at Al Qassimi & Kuwait Hospitals, Sharjah , UAE , from
June 2003 onwards.
Clinical Assistant Professor of Medicine & Gastroenterology at Sharjah University, College of Medicine from June 2008.
Currently : Member, Hepatology Group, World Gastroenterology Organization, 2013 – 2015.
ZAHER KOUTOUBI
Consultant, Gastroenterology
Digestive Disease Institute
Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE
Dr. Koutoubi is Consultant in Gastroenterology & Hepatology in Digestive Disease Institute at
Cleveland Clinic Abu Dhabi. Digestive Disease Institute is one of the five Centers of Excellence
at Cleveland Clinic Abu Dhabi.
Dr. Koutoubi joined Digestive Disease Institute at Cleveland Clinic Abu Dhabi in August 2014.
Prior to Joining Cleveland Clinic Abu Dhabi he worked as Consultant in Gastroenterology & Hepatology at Tawam Hospital
in Al Ain, UAE between 2005 and 2014. He also served as the Chairman of the Clinical Peer Review Committee from 2008
till 2014.
He is very interested in all aspects of gastroenterology, hepatology, liver transplantation, inflammatory bowel disease and
endoscopy with special interest in the field of Hepatology. He is also very active in research and was involved in many
research projects especially Hepatitis B, Hepatitis C and gastrointestinal bleeding. He presented his research data regarding
gastrointestinal bleeding, hepatitis B and hepatitis C treatment experience during national and international gastroenterology
meetings.
Dr. Koutoubi did his internal medicine residency training at Wright State University in Dayton, Ohio (USA), and did his
Gastroenterology fellowship training at Saint Louis University in Saint Louis, Missouri, USA, and he is American Board
Certified in Gastroenterology since 2000 and re-certified in 2010.
Dr. Koutoubi serves on the editorial boards of several scientific journals including JGIM (Journal of General Internal
Medicine), and Gastroenterology & Hepatology, Open Access.
Dr. Koutoubi is a member of the Emirates Medical Association and Emirates Gastroenterology Association.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
FUAD AL ALI
Professor of Internal Medicine and Gastroenterology
Institute: Faculty of Medicine, Kuwait University
Graduated from medical school in 1984.
Completed Internal Medicine and Hepatology at the University of Miami
Assistant Professor at the University of Texas, San Antonio.
Professor and former Dean of the Faculty of Medicine, Kuwait University.
ALI ALBAQALI
Professional Summary I have finished medical school in 1997, Cairo University/Egypt. joined internal
medicine residency in 1998-2003 at Salmaniya Medical Complex/Kingdom of Bahrain, finished the
Arab Board Certificate. I joined Leonard M.Miller University of Miami/ Florida Gastroenterology and
Hepatology Fellowship 2003-2006. Clinical and Transplant Hepatology 2006-2007 in Leonard M.Miller
School of Medicine University of Miami/Florida. 2007-until now , Consultant Gastroenterology and
Hepatology at Salmaniya Medical Complex / Kingdom of Bahrain. Chairman of Gastroenterology and
Hepatology Unit SMC/Kingdom of Bahrain. Senior Lecturer at RCSI-MUB( Royal College of SurgeonBahrain)
AHMAD HOMOUD SAAD AL-HAZMI
Family physician consultant, (consultant, associated Professor)
Scientific life:
MBBS from King Saud university (1414-1415 AH).
Master degree in primary health care from King Saud University (college of medicine- 1999).
Diploma in the e-learning from (Busan, Seoul) South Korea.
3 boards (doctorates) in the family and community medicine.
Attendance many national & international conferences in/ and outside Saudi Arabia.
Many publications in medical journals and many posters and orals in many national and
international conferences.
International speaker in many countries [ e.g. USA, China, Singapore, Malaysia, Spain
Speaker in many national conferences [at Riyadh city & Riyadh province], also, trainer for all HCWS including doctors in
many health care issues [DM, HTN, BA, IBS, ECG, etc.
Referee in: Journal of infection and public health; (http://www.jiph.org/home); [ELSEVIER- Full Text Article, & PubMedhttp://
www.ncbi.nlm.nih.gov/pubmed/]. Annals of Saudi medicine; (http://www.annsaudimed.net/); [PubMed].
Practical life:
Intern (house officer) at King Khalid University hospital and Riyadh medical complex in Riyadh (1414-1415 AH). Resident
in pediatric hospital at Riyadh (1415-1417 AH). Attached to Saudi board for 4 years in college of medicine at king Saud
University. Senior registrar at Riyadh general health directorate and the Consultant family physician for 4 years. Former
consultant for the “vise the minister of health” in the development of the primary health care in Saudi Arabia.
Former dean College of medicine at AlJouf University for 3 years.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
HUSSIEN ELSIESY
King Faisal Specialist Hospital and Research Center, Riyadh Saudi Arabia 11211
Cairo University School of Medicine, Kaser El-aini, Cairo, Egypt
October 1988 – May 1996
AWARDS
• AASLD fellowship Award 2005.
• Highest National In-training Award – Ranked 97% in nation, May 1999
• Best Intern Award, August 1999
• Monthly Monetary Award, October 1998- December 1994
CREDENTIALS AND LICENSES
• New York Medical License #223659
• American Bo9ard of Transplant Hepatology – 2006
• American Board of Gastroenterology –2005.
• American Board of Internal Medicine - 2001
ABDEL MEGUID KASSEM
Professor, Department of Endemic Diseases, Cairo University, Egypt
Abdel Meguid Kassem completed his medical studies at Cairo University where he graduated in 1990
and received his M.D. in 2000. He currently works as a full professor in the Department of Endemic
Diseases, Cairo University. From 1996-1998, Kassem received a scholarship from the German
Academic Exchange Service (DAAD). In recognition of his efforts and contributions he was rewarded
with many other distinctions, such as the Young Clinician Programme scholarship. Kassem is a
member of several renowned national and international professional committees and advisor to
several governmental organizations. He is member of the national committee on drafting legislations
for clinical trials in Egypt. His current research portfolio includes colonic cancer, endoscopic retrograde cholangiopancreatography
(ERCP) and endoscopic ultrasound
GAMAL ESMAT
Vice President for Graduate Studies and Research,Cairo University.
Professor of Tropical Medicine and Hepatology,Faculty of Medicine,
Cairo University.
Director of the Viral Hepatitis Treatment Centers.Ministry of Health.Egypt
Dr. Esmat was past president of the International Association for the Study of the Liver (IASL),
2006-2008. He is currently a board member of the strategic and technical advisory committee
for viral hepatitis (STAC-Hep), WHO and member of the scientific committee for the World
Hepatitis Alliance. Dr. Esmat has served as principal investigator of numerous research studies
in Egypt and has a long list of international and regional publications in the field of hepatology. He has also been included
in the Who’s Who biography book as one of the most effective contributors to the field of hepatology (2007) and was
nominated as one of the top 100 health professionals in 2008 by an international biographical center in the United Kingdom.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
MAMDOUH AHMED GABR
Tanta Faculty of Medicine - Tanta - Egypt
Professor of Hepato-Gastroenterology
City: Tanta, Egypt
TAREK QUTOB
Assistant Professor of Medicine
Currently at the private medical sector in Amman, JORDAN.
Board Certification
American Board of Transplant Hepatology
American Board of Gastroenterology
American Board of Internal Medicine
American Board of clinical nutritionist specialists
Education:
Gastroenterology and Transplant Hepatology fellowships from The University of Rocheter Medical Center, Rochester NY,
USA.
Internal medicine residency from University of Buffalo, Buffalo NY, USA.
Medical degree from University of Jordan.
ZEYAD K. SHARAIHA
• Former Member of the Upper House of Parliament (Senate)
• International Advisor for the Royal College of Physicians (London)
• Reviewer abstracts in the European Gastroenterology Week (UEGW)
• Member of Higher Medical Council of Jordan
• Founding President of AMAGE (African Middle East Association of Gastroenterology) Since January
2000
• Former President &Consultant of Private Doctors Association in Jordan
• Honorary President of the Pan Arab Association
• Medical Consultant for the Royal House Hold in Jordan
• Member of the Higher Council for Housing.
• Member of board of trustees for university hospital. Amman
• Working group International committee ASGE
• GLOBAL MENTOR nominated By WGO 2008
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
MARK GHOBRIAL
Director , Methodist Center for Liver Disease & Transplantation
Chief, Liver Transplantation Surgery
Director, Immunobiology Research Center
R. Mark Ghobrial, M.D., Ph.D., FACS, FRCS (Ed) joined Houston Methodist Research Institute
as Director of Immunobiology Biology Research Center in March 2008. He is also the Director
of the Center for Liver Disease & Transplantation at Houston Methodist. Dr. Ghobrial was
previously at University of California, Los Angeles (UCLA), one of the largest liver transplant
centers in the world.
Dr. Ghobrial obtained his M.D. degree at the Cairo University Medical School. He completed his Internship at Massachusetts
General Hospital in Boston, Surgery Residency at University of Texas Health Science Center at Houston and a Multi-organ
Transplantation Fellowship at University of California, Los Angeles (UCLA).
DAVID W. VICTOR III, MD
Transplant Hepatology/Gastroenterology
Dr. Victor is board certified in internal medicine and gastroenterology. He received his medical
degree from the University of Kentucky and completed residency training in internal medicine
at Tulane University in New Orleans, La. He followed this with a fellowship in gastroenterology
and hepatology at Tulane University and a fellowship in transplant hepatology at Johns Hopkins
School of Medicine in Baltimore, Md., where he was an instructor of medicine with the division
of gastroenterology before joining Houston Methodist Hospital.
VICTOR FAINSTEIN
Dr. Victor Fainstein obtained his medical degree with high honors from Universidad Nacional
Autónoma de México (UNAM). He completed his residency at the National Institute of Health
Sciences and Nutrition Salvador Zubirán in Mexico City. Dr. Fainstein completed his first
fellowship in infectious diseases and microbiology at Baylor College of Medicine and a second
fellowship focused on infectious diseases in the compromised host at MD Anderson Hospital
and Tumor Institute. Dr. Fainstein practiced at MD Anderson Hospital for 8 years before moving
to Houston Methodist Hospital. He currently serves as Chief of Infectious Diseases Department
and as Medical Director and Senior Advisor to Houston Methodist Global Health Care Services.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
PROFESSOR DANIEL PALMER
North west Cancer Research Professor and Honorary Consultant in Medical
Oncology, University of Liverpool
Professor Palmer graduated in Medicine from the University of Birmingham in 1995 having
intercalated in the Institute for Cancer Studies undertaking research investigating defective p53
responses in patients with the radio sensitivity disorder Ataxia-Telangiectasia, achieving a BSc
with first class honours.
After general medical training leading to MRCP (UK) he began Medical Oncology training. Within
this he was awarded a Medical Research Council Clinical Training Fellowship to undertake research investigating a novel
enzyme-prodrug cancer gene therapy strategy, this leading to his PhD and to publication of the first clinical experience of
this therapy in patients with primary and secondary liver cancer. He then completed specialist training, winning the
Association of Cancer Physicians McElwain Scholarship in 2005, funding a brief sabbatical at the Chinese University of
Hong Kong.
In 2005 he took up his current position of Cancer Research UK Clinician Scientist and Honorary Consultant in Medical
Oncology at the University of Birmingham and University Hospital Birmingham NHS Trust. In 2011, he took the Clatterbridge
Cancer Research Chair in Medical Oncology at the University of Liverpool.
His research interests relate to HPB cancers (pancreas, liver and biliary tract) and incorporate basic laboratory science,
translational research and clinical trials. His laboratory research is currently investigating novel therapeutic approaches to
the treatment of HPB cancers. This involves the identification of potential targets expressed by the cancers that may allow
recognition by the immune system using state-of-the-art proteomic and phosphoproteomic techniques, and investigating
strategies to stimulate an immune response against the cancer. In particular, he is investigating a molecule called CD40,
which is commonly expressed by HPB cancers and which, if stimulated in the appropriate way may induce cancer cell
death as well as promoting an anti-cancer immune response. He has established a portfolio of early phase clinical trials
and translational studies in this field as well as making significant contributions to multi-centre phase III trials and is the UK
lead for the SORAMIC trial.
CHRISTOPHE DUVOUX
Professor Christophe Duvoux, MD, is full professor of Hepatology at the University Paris Est
Creteil (UPEC), working at the Department of Hepatology and at the Liver Transplant Unit of
the Universitary Hospital Henri MONDOR, where he leads the medical aspects of liver
transplantation. He is Vice Chairman of the European Liver and Intestine Transplantation Society
(ELITA) and a Member of the French and European Societies for Study of Liver Diseases (AFEF
and EASL). He is also Junior Secretary of the UEMS (EU medical school) of Transplantation
Medicine, member of of the council of the French Transplantation Society,and member of the
Scientific Committee of the French Organ Sharing Organization (ABM). His research focuses
on clinical aspects of liver tranplantation especially HCC & liver transplantation, immunosuppressive regimens, and antibodymediated rejection. Pr Duvoux is primary investigator of several ongoing multicenter clinical trials in the field of liver
transplantation and involved in educational initiatives at the French and European level. He is author/coauthor of > 100
international manuscripts.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
CHRISTOPHE HÉZODE
Christophe Hézode, MD, PhD, has been a hepatologist in the Department of Hepatology, Henri
Mondor Hospital, University Paris-Est, Créteil, France, since 1996. He is member of the
INSERM U955 group directed by Professor Jean-Michel Pawlotsky. Professor Hézode’s
research experience is focused on viral hepatitis and he is the author of 115 papers published
in peer-reviewed medical or scientific journals. He is the head of the French early access
program for the use of first generation protease inhibitors (CUPIC cohort). He is also member
of several professional societies or organisations including the French Association for the Study
of the Liver (AFEF), the French National Agency for AIDS and Viral Hepatitis Research (ANRS)
and the European Association for the Study of the Liver (EASL).
JEAN-MICHEL PAWLOTSKY
ACADEMIC POSITIONS:
Dr Jean-Michel Pawlotsky is Professor of Medicine at the University of Paris-Est. He is the
Director of the National Reference Center for Viral Hepatitis B, C and Delta and of the
Department of Virology at the Henri Mondor University Hospital in Créteil, France, and Director
of the Department of Molecular Virology and Immunology at the 'Institut Mondor de Recherche
Biomédicale' (INSERM U955).
EDUCATION:
Dr Pawlotsky earned his medical degree in Hepatology andmore» Gastroenterology in 1992.
In addition, he earned a Thesis in molecular virology from the University of Paris, France, and he is a graduate in virology
from the Pasteur Institute in Paris and microbiology from the University of Paris.
PROFESSIONAL ACTIVITIES:
Dr Pawlotsky is active in numerous professional societies, and has been acting as the Secretary General of the European
Association for the Study of the Liver (EASL) between 2005 and 2009. He is a member of the Scientific College and
President of Scientific Commission 4 (CSS4) and Concerted Action 33 (AC33) of the French National Agency for AIDS and
Viral Hepatitis Research (ANRS). Dr Pawlotsky has been an Associate Editor of Hepatology, the official journal of the
American Association for the Study of Liver Diseases (AASLD), between 2001 and 2006, and is currently an Associate
Editor of Gastroenterology, the official journal of the American Gastroenterological Association (AGA). He is a member of
the Editorial Board of the Journal of Hepatology, Therapeutic Advances in Gastroenterology, and European Gastroenterology
and Hepatology Review.
RESEARCH INTERESTS:
Dr Pawlotsky focuses on teaching, diagnosis and research in virology, primarily hepatitis viruses. His noted career
contributions include the publication of over 350 articles and book chapters in his areas of expertise
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
HOLGER MICHAEL HINRICHSEN
School:
1969-1973 elemantary school in Cuxhaven;1973-1982 Gymnasium Cuxhaven (college);
Military:1982-1983 German army forces
University:
1983-1990 Faculty of Medicine in Kiel;1985 Physicum
01.01.1992 Medical licence by the Government of Schleswig-Holstein, Kiel
Doctoral thesis:
1987 -1990 „Hämatologisch-immunologische Parameter unter akustischem Stress bei Patientinnen mit systemischem Lupus
erythematodes, Patienten mit Sarkoidose und gesunden Vergleichspersonen“.1991 docotor degree: magna cum laude
Postgraduate training:
7/90-12/90 surgery in Kiel from 1/1991 until 12/2006 fellow in the department of internal medicine at the university of Kiel, Germany
Since 1993 member of the hepatology unit of the university; Medical licence in Internal Medicine 26.Nov.1997; Medical licence in
Gastroenterology 25.Oct. 2000. Since 01.01.2007 working at a private practice (GHZ Kiel)
Publications:
More than 50 original papers in reviewed journals (i.e. Gastroenterology, Hepatology, GUT, Nephrology Dialysis and
Transplantation, Clinical Pharmacology and Therapeutics; European Journal of Clinical Investigation; British Medical Journal,
Rheumatology International, Journal of Hepatology).Review articles (i.e. Clinical Pharmacology, European Journal of Clinical
Investigation) Co-editor of a supplement of the European Journal of Clinical Investigation; Co-author of books; more than 60
published abstracts following oral or poster presentation
Expertise:
in clinical studies-Since 1996 involved in several clinical trials (i.e. FDA trials phase2 and 3); principal investigator in a phase 2a
FDA trial in 2001/2002
LAURA T. KASSYM
Laura T. Kassym, is receiving her PhD in Semey State Medical University (SSMU), Republic of
Kazakhstan. Following completion of her residency at the Gastroenterology & Hepatology
Department of Medical Center of SSMU, she joined the faculty of the Department of Internal
Diseases of SSMU (2013). She has been and continues to be the junior research fellow on a
scientific and technical program of MOH RK that investigates epidemiological, clinical and
diagnostic aspects in chronic liver diseases, assessing quality of life, differences in treatment
of people who live in area of former Semey Nuclear Test Site. Her doctoral work is focused on
clinical and pathogenetic peculiarities of hepatobiliary system pathology, with an emphasis on
characterizing the diagnostics and treatment of non-viral liver diseases.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
MAURIZIO POMPILI
Graduated cum laude in Medicine and Surgery at the Catholic University of Sacred Heart (1983)
Specialized in Gastroenterology and Digestive Endoscopy (1987) and in Internal Medicine (1994)
PhD in "Physiopathology of nutrition and metabolism" (1992)
Assistant Professor in the Department of Internal Medicine and Geriatrics of the Catholic University
of Sacred Heart from (1995)
Confirmed Assistant Professor in the Department of Internal Medicine and Geriatrics of the Catholic
University of Sacred Heart (2000)
Associate Professor - group MED 09 - Department of Internal Medicine of the Catholic University of
Sacred Heart (2006)
Confirmed Associate Professor - Group MED 09 - Department of Internal Medicine of the Catholic University of Sacred Heart from
2009 up to now
Professor in the School of Medicine of the Catholic University of Sacred Heart
Professor in the Specialization Schools of Gastroenterology and Internal Medicine of the Catholic University of Sacred Heart
Secretary of the Specialization School of Internal Medicine and of the Post-Graduation Master in “Diagnostic Ultrasound in Internal
Medicine and Ultrasound-guided therapies” of the Catholic University of Sacred Heart
Invited to give lectures mainly concerning liver ultrasound and hepatocellular carcinoma in several National and International
Congresses. Co-author of more than 350 scientific papers including more than 110 papers peer reviewed and published in journals
with Impact Factor – H-index: 23
Main fields of interest are hepatocellular carcinoma, liver transplantation, liver ultrasound, liver cirrhosis and related complications
OXANA DRAPKINA
Russian Academy of Medical Sciences
Secretary of Therapeutic Council
• NAFLD Syndrome Management, National Expert
• Russian Epidemiological Study for Fatty Liver, National Curator
• Program “Nitric Oxide in patients with Acute Myocardial Infarction and Heart Failure”, Senior
Researcher
First Moscow State Sechenov Medical University
Professor
• Centre of Innovative Medicine, Deputy Director
• Clinic of Internal Diseases, Head of Cardiovascular Department
• Student Scientific Pirogov Society, Head of Therapeutic Research Section
Russian National Internet Society of Internal Medicine: Vice President
Russian Cardiology Association: Section IT in Cardiology, Chairman
Russian CME Program for Internists INTERNET SESSION® : Executive Director
Journal Russian Medical News /Российские медицинские вести/ ISSN 1029-8126: Deputy Editor-in-Chief
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
FACULTY
KAISER RAJA
Consultant Transplant Hepatologist Global Integrated Liver Care Program
BGS Global Hospitals Bangalore (India
Dr. Kaiser Raja, is a Consultant in Hepatology and the Chief Transplant Hepatologist for the
Integrated Liver Care Program of Global Hospitals in Bangalore in India. He has done his
residency in Internal Medicine and a fellowship in Gastroenterology from the renowned
Postgraduate Institute of Medical Education and Research at Chandigarh in India. He has
practised as a Consultant Gastroenterologist in Abu Dhabi from 2003 to 2008. He then did an
Advanced fellowship in Liver Diseases and Transplant Hepatology from the Mount Sinai Medical
Centre in New York. Following this he has established a Centre for Advanced Liver Diseases
and Liver Transplantation at Global Hospital in Bangalore, India where both deceased donor and living donor liver transplants
are done. Apart from transplants, his Integrated Liver Care Group has a strong interest in liver cancer, hepatobiliary surgery,
advanced chronic liver diseases, paediatric hepatology, acute liver failure and interventional liver radiology. Dr. Kaiser Raja
also has his ILC Foundation which helps in promoting awareness for hepatitis B and C, and has initiated a low cost paediatric
transplant program in association with the government of the state of Karnataka, India. Dr. Kaiser Raja continue to visit
UAE as a consultant in liver diseases.
NOTES
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
DIAMOMD SPONSORS
JANSEN
At Janssen, we collaborate with the world for the health of everyone in it.
At Janssen, what matters most to us is a healthy outcome for each patient. We’re committed to
providing safe and effective medicines as well as the services and support that contribute to healthy
outcomes.
At Janssen, We are committed to make the world without Hepatitis C, one patient at a time by
addressing unmet medical needs in the treatment of hepatitis C through science and innovation We
work hand in hand with industry partners, healthcare professionals, non-governmental organizations,
charities and patients today to make Hep-C prevention, diagnosis and treatment accessible and
affordable to patients worldwide. As Janssen, we are passionately pursuing science for the benefit
of all patients.
After all, our responsibility as a Credo-driven, Johnson & Johnson company is to put people first. We
collaborate with the world for the health of everyone in it.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
PLATINUM SPONSOR
ABBVIE
A NEW BIOPHARMACEUTICAL COMPANY, A RICH
HERITAGE
AbbVie represents a new biopharmaceutical company,
combining the expertise and stability of a long-standing
pharmaceutical company with the focus and innovative spirit
of biotech.
REMARKABLE IMPACT
AbbVie has a portfolio of compounds in clinical trials and hundreds of patents for Immunology, Hepatology,
Neuroscience, Oncology and Women’s Health.
We lead with patient-centered approaches and collaborate with peers, clinical experts, governments and
advocacy groups – people like you – to deliver new solutions that truly make a difference for patients.
ABBVIE’S COMMITMENT
Our commitment to creating impact for patients brings clarity to our work.
We invite you to learn more about AbbVie and to partner with us as we build our future.
abbvie.com
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
GOLD SPONSORS
GILEAD SCIENCES
• Company Name: Gilead Sciences
• Contact Person: Reham Ashry
• Contact Phone Number: 0505980310
• Email Address: [email protected]
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and
commercializes innovative medicines in areas of unmet medical need. With each new discovery and
investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases
around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation,
and serious respiratory and cardiovascular conditions.
SIRTEX MEDICAL EUROPE
GMBH
• Company Name: Sirtex Medical Europe GmbH
• Contact Person: Ms Janine Dornbusch
• Contact Phone Number: +49 228 1840730
• E-mail Address: [email protected]
• Homepage: www.sirtex.com
Sirtex company profile
Sirtex is a global life-sciences company that develops and delivers effective oncology treatments using SIRSpheres® microspheres (Yttrium-90 resin beads). This innovative technology is presently used to treat a variety
of unresectable liver tumours at 250+ institutions in Europe and the Middle East, 380+ centres in North America
and 100+ in Asia-Pacific region.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
EXHIBITORS
ASTRAZENECA
AstraZeneca’s innovative medicines are used by millions of
patients worldwide. We want to be valued as a source of great
medicines and trusted as a company that delivers business success responsibly. We are committed to operating
with integrity and high ethical standards across all our activities.
BRISTOL-MYERS
SQUIBB MIDDLE EAST
& AFRICA
FZ-LLC
Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and
deliver innovative medicines that help patients prevail over serious diseases. Our medicines help millions of
people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B, Hepatitis C, HIV/AIDS,
rheumatoid arthritis and psychiatric disorders.
DR. FALK PHARMACEUTICALS
Dr. Falk Pharma GmbH is an independent family firm based in Freiburg,
Germany.
Our company specializes in the development of medication for indications in
hepatology and gastroenterology.
The Falk Foundation is an independent organization, offering a wide variety
of events to support postgraduate courses on a national and international level.
ELSEVIER
Amirsys, Inc. is a leading provider of innovative healthcare
information solutions in radiology, pathology, and anatomy. Our
unique combination of proprietary technology and imageintensive, evidence-based content provide online problem-solving solutions and reference books to thousands
of physicians and health professionals worldwide.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
EXHIBITORS
FERRING PHARMACEUTICALS
Ferring Pharmaceuticals is research-driven biopharmaceutical company
devoted to identifying and marketing products in:
• Urology
• Reproductive Health
• Gastroenterology
• Endocrinology.
Ferring corporate headquarters in Switzerland.
Ferring Middle East Regional Office established in 1996 in Jordan to operate activities throughout the region
Ferring offering leading portfolio to provide tailored treatments functioning on body’s own terms.
GULFMED FZE
Established in 2003, GulfMed – One of Al Moosa Healthcare
group of companies. GulfMed is a healthcare & well-being
products provider, specialized in serving regional and
international clients. Providing quality pharmaceutical, medical, home healthcare & well-being products.
Our MOH licensed warehouse located strategically in Dubai Airport Free Zone Area.
HOVID BHD
Hovid, a Malaysian R&D pharmaceutical company that is active
in the development and manufacturing of the pharmaceutical
specialties serving over 50 countries around the world.
At Hovid, we strive to make quality, reliability and innovation as our business culture. Innovation is the key to
our growth and excellent customer service is our priority.
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
EXHIBITORS
JULPHAR
Julphar is a true reflection of Ras Al Khaimah’s significant
development which established in 1980.
The objective was to produce high-quality, affordable medicines
to people in the UAE. Over three decades later, we are a leading
global company with twelve facilities who provides high-quality,
affordable products to over 40 countries.
Julphar is an example of one of the UAE’s local businesses making an impact on the global stage.
LUNATUS
Since its inception in 2003, Lunatus Marketing & Consulting has
established a successful track record in introducing, building and
developing profitable brands in the fields of Pharmaceuticals, Rx
& OTC, Aesthetic medicine & skin care, Consumer Health, and
medical equipment.
OLYMPUS
Olympus is one of the world’s leading manufacturers of
innovative optical and digital equipment such as endoscopes
and microscopes for medical field.Since Founded in Japan in
1919, Olympus continues to provide cutting-edge medical
technology to healthcare professionals around the globe and in
the pursuit of the perfect endoscopy system.
MPC
MPC’s specialised medical business unit brings to it’s customers
bundled solutions and innovative products.
Siemens Healthcare ultrasound systems with dedicated liver
elastography (ARFI)
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
ACKNOWLEDGMENT
DIAMOND SPONSORS
PLATINUM SPONSOR
GOLD SPONSORS
EXHIBITORS
www.InfoPlusEvents.com/Liver
2ND GULF LIVER
SUMMIT
NOTES
www.InfoPlusEvents.com/Liver